Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 8/2017

20.10.2016 | Originalien

The effects of high serum growth hormone and IGF-1 levels on bone mineral density in acromegaly

verfasst von: S. Tuzcu, MD Ş. A. Durmaz, A. Carlıoğlu, Z. Demircan, A. Tuzcu, C. Beyaz, A. Tay

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) play a major role in bone homeostasis. In this study, we aimed to assess bone mineral density (BMD) in active acromegaly.

Materials and methods

A total of 29 patients with active acromegaly (age 46.10 ± 13.27 years; body mass index [BMI]: 29.51 ± 4.91 kg/m2) and 42 healthy individuals matched for age and BMI (age: 40.35 ± 11.74 years; BMI: 28.18 ± 7.35 kg/m2) were included in the study. BMD was measured by DXA.

Results

The mean levels of GH and IGF-1 were found to be 12.61 ± 11.34 ng/ml and 676.47 ± 316.19 ng/ml in acromegaly, respectively, while the mean levels of GH and IGF-1 were found to be 0.59 ± 0.81 ng/ml (p = 0.0001) and 178.17 ± 57.11 ng/ml (p = 0.0001) in the control group, respectively. Only total hip t‑score was determined to be significantly lower in acromegaly compared to the control group (p = 0.037). No significant differences were found between the other parameters in DXA and only a positive correlation was found between IGF-1 levels and L1–L4 BMD (r = 0.259, p = 0.029).

Conclusions

Although GH and IGF-1 levels were increased in acromegalic patients, no significant difference was found in terms of vertebral BMD. Only hip t‑scores were found to be lower in acromegalic patients, but this low hip t‑score did not reach the osteopenic level. The positive correlation between IGF-1 and lumbar vertebral BMD suggested a more prominent effect of IGF-1 on BMD compared to GH.
Literatur
2.
Zurück zum Zitat Rajasoorya C, Holdaway IM, Wrightson P et al (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95–102CrossRef Rajasoorya C, Holdaway IM, Wrightson P et al (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95–102CrossRef
3.
Zurück zum Zitat Ahmed SF, Farquharson C (2010) The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol 206(3):249–259CrossRefPubMed Ahmed SF, Farquharson C (2010) The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol 206(3):249–259CrossRefPubMed
4.
Zurück zum Zitat Kasukawa Y, Miyakoshi N, Mohan S (2004) The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10(21):2577–2592CrossRefPubMed Kasukawa Y, Miyakoshi N, Mohan S (2004) The anabolic effects of GH/IGF system on bone. Curr Pharm Des 10(21):2577–2592CrossRefPubMed
5.
Zurück zum Zitat Chihara K, Sugimoto T (1997) The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts. Horm Res 48(Suppl 5):45–49CrossRefPubMed Chihara K, Sugimoto T (1997) The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts. Horm Res 48(Suppl 5):45–49CrossRefPubMed
6.
Zurück zum Zitat Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J (2006) Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur J Endocrinol 155(5):709–715CrossRefPubMed Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J (2006) Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur J Endocrinol 155(5):709–715CrossRefPubMed
7.
Zurück zum Zitat DiGirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL (2007) Mode of growth hormone action in osteoblasts. J Biol Chem 282(43):31666–31674CrossRefPubMed DiGirolamo DJ, Mukherjee A, Fulzele K, Gan Y, Cao X, Frank SJ, Clemens TL (2007) Mode of growth hormone action in osteoblasts. J Biol Chem 282(43):31666–31674CrossRefPubMed
8.
Zurück zum Zitat Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F (2005) Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. Eur J Endocrinol 152(1):53–60CrossRefPubMed Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F (2005) Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly. Eur J Endocrinol 152(1):53–60CrossRefPubMed
9.
Zurück zum Zitat White HD, Ahmad AM, Durham BH, Joshi AA, Fraser WD, Vora JP (2011) Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency. J Clin Endocrinol Metab 96(3):726–736CrossRefPubMed White HD, Ahmad AM, Durham BH, Joshi AA, Fraser WD, Vora JP (2011) Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency. J Clin Endocrinol Metab 96(3):726–736CrossRefPubMed
11.
Zurück zum Zitat Padova G, Borzì G, Incorvaia L, Siciliano G, Migliorino V, Vetri M, Tita P (2011) Prevalence of osteoporosis and vertebral fractures in acromegalic patients. Clin Cases Miner Bone Metab 8(3):37–43PubMedPubMedCentral Padova G, Borzì G, Incorvaia L, Siciliano G, Migliorino V, Vetri M, Tita P (2011) Prevalence of osteoporosis and vertebral fractures in acromegalic patients. Clin Cases Miner Bone Metab 8(3):37–43PubMedPubMedCentral
12.
Zurück zum Zitat Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr Rev 25:102–152CrossRefPubMed Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr Rev 25:102–152CrossRefPubMed
13.
Zurück zum Zitat Morselli LL, Manetti L, Cosci C et al (2006) Bone and joint alterations in acromegaly. J Orthop Traumatol 7:169–175CrossRefPubMedCentral Morselli LL, Manetti L, Cosci C et al (2006) Bone and joint alterations in acromegaly. J Orthop Traumatol 7:169–175CrossRefPubMedCentral
14.
Zurück zum Zitat Ho PJ, Fig LM, Barkan AL, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33(9):1608–1612PubMed Ho PJ, Fig LM, Barkan AL, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33(9):1608–1612PubMed
15.
Zurück zum Zitat Kotzmann H, Bernecker P, Hübsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G, Luger A (1993) Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 8(4):459–465CrossRefPubMed Kotzmann H, Bernecker P, Hübsch P, Pietschmann P, Woloszczuk W, Svoboda T, Geyer G, Luger A (1993) Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 8(4):459–465CrossRefPubMed
16.
Zurück zum Zitat Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V, Liuzzi A (2003) Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin Endocrinol (Oxf) 58(6):725–731CrossRef Scillitani A, Battista C, Chiodini I, Carnevale V, Fusilli S, Ciccarelli E, Terzolo M, Oppizzi G, Arosio M, Gasperi M, Arnaldi G, Colao A, Baldelli R, Ghiggi MR, Gaia D, Di Somma C, Trischitta V, Liuzzi A (2003) Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status. Clin Endocrinol (Oxf) 58(6):725–731CrossRef
17.
Zurück zum Zitat Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, AACE Acromegaly Task Force (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly–2011 update: executive summary. Endocr Pract 17(4):636–646CrossRefPubMed Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, AACE Acromegaly Task Force (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly–2011 update: executive summary. Endocr Pract 17(4):636–646CrossRefPubMed
18.
Zurück zum Zitat Bolanowski M, Daroszewski J, Medraś M, Zadrozna-Sliwka B (2006) Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 24(1):72–78CrossRefPubMed Bolanowski M, Daroszewski J, Medraś M, Zadrozna-Sliwka B (2006) Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab 24(1):72–78CrossRefPubMed
19.
Zurück zum Zitat Giuseppina P, Graziella B, Laura I et al (2011) Prevalence of osteoporosis and vertebral fractures in acromegalic patients. Clin Cases Miner Bone Metab 8(3):37–43 Giuseppina P, Graziella B, Laura I et al (2011) Prevalence of osteoporosis and vertebral fractures in acromegalic patients. Clin Cases Miner Bone Metab 8(3):37–43
20.
Zurück zum Zitat Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649–4655CrossRefPubMed Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649–4655CrossRefPubMed
22.
Zurück zum Zitat Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J Bone Miner Res 20(10):1837–1844CrossRefPubMed Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J Bone Miner Res 20(10):1837–1844CrossRefPubMed
23.
Zurück zum Zitat Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonça LM, Gadelha MR, Fleiuss de Farias ML (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734–1741CrossRefPubMed Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonça LM, Gadelha MR, Fleiuss de Farias ML (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734–1741CrossRefPubMed
24.
Zurück zum Zitat Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164(4):475–483CrossRefPubMed Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164(4):475–483CrossRefPubMed
25.
Zurück zum Zitat Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76(6):1452–1457PubMed Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR (1993) Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76(6):1452–1457PubMed
26.
Zurück zum Zitat Hübsch P, Kotzmann H, Svoboda T, Kainberger FM, Bankier A, Seidl G (1993) Bone density of the lumbar spine and femur in acromegaly. Radiologe 33(8):457–461PubMed Hübsch P, Kotzmann H, Svoboda T, Kainberger FM, Bankier A, Seidl G (1993) Bone density of the lumbar spine and femur in acromegaly. Radiologe 33(8):457–461PubMed
27.
Zurück zum Zitat Jockenhövel F, Rohrbach S, Deggerich S, Reinwein D, Reiners C (1996) Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly. Eur J Med Res 1(8):377–382PubMed Jockenhövel F, Rohrbach S, Deggerich S, Reinwein D, Reiners C (1996) Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly. Eur J Med Res 1(8):377–382PubMed
28.
Zurück zum Zitat Ueland T (2005) GH/IGF-I and bone resorption in vivo and in vitro. Eur J Endocrinol 152(3):327–332CrossRefPubMed Ueland T (2005) GH/IGF-I and bone resorption in vivo and in vitro. Eur J Endocrinol 152(3):327–332CrossRefPubMed
29.
Zurück zum Zitat Jean Ho P, Lorraine M, Barkan A, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33:1608–1612 Jean Ho P, Lorraine M, Barkan A, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 33:1608–1612
30.
Zurück zum Zitat Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21(9):1350–1358CrossRefPubMed Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21(9):1350–1358CrossRefPubMed
31.
Zurück zum Zitat Neve A, Corrado A, Cantatore FP (2011) Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 343(2):289–302CrossRefPubMed Neve A, Corrado A, Cantatore FP (2011) Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 343(2):289–302CrossRefPubMed
33.
Zurück zum Zitat Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B (2001) The skeletal structure of insulin-like growth factor I‑deficient mice. J Bone Miner Res 16(12):2320–2329CrossRefPubMed Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B (2001) The skeletal structure of insulin-like growth factor I‑deficient mice. J Bone Miner Res 16(12):2320–2329CrossRefPubMed
34.
Zurück zum Zitat Bach LA (2004) The insulin-like growth factor system: towards clinical applications. Clin Biochem Rev 25(3):155–164PubMedPubMedCentral Bach LA (2004) The insulin-like growth factor system: towards clinical applications. Clin Biochem Rev 25(3):155–164PubMedPubMedCentral
35.
Zurück zum Zitat Garnero P, Sornay-Rendu E, Delmas PD (2000) Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355(9207):898–899CrossRefPubMed Garnero P, Sornay-Rendu E, Delmas PD (2000) Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355(9207):898–899CrossRefPubMed
36.
Zurück zum Zitat Friedlander AL, Butterfield GE, Moynihan S, Grillo J, Pollack M, Holloway L, Friedman L, Yesavage J, Matthias D, Lee S, Marcus R, Hoffman AR (2001) One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab 86(4):1496–1503PubMed Friedlander AL, Butterfield GE, Moynihan S, Grillo J, Pollack M, Holloway L, Friedman L, Yesavage J, Matthias D, Lee S, Marcus R, Hoffman AR (2001) One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab 86(4):1496–1503PubMed
37.
Zurück zum Zitat Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205(3):201–210CrossRefPubMed Perrini S, Laviola L, Carreira MC, Cignarelli A, Natalicchio A, Giorgino F (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J Endocrinol 205(3):201–210CrossRefPubMed
Metadaten
Titel
The effects of high serum growth hormone and IGF-1 levels on bone mineral density in acromegaly
verfasst von
S. Tuzcu
MD Ş. A. Durmaz
A. Carlıoğlu
Z. Demircan
A. Tuzcu
C. Beyaz
A. Tay
Publikationsdatum
20.10.2016
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 8/2017
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-016-0171-6

Weitere Artikel der Ausgabe 8/2017

Zeitschrift für Rheumatologie 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.